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The F-BAR protein pacsin2 inhibits asymmetric
VE-cadherin internalization from tensile adherens
junctions
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Vascular homoeostasis, development and disease critically depend on the regulation of
endothelial cell–cell junctions. Here we uncover a new role for the F-BAR protein pacsin2 in
the control of VE-cadherin-based endothelial adhesion. Pacsin2 concentrates at focal
adherens junctions (FAJs) that are experiencing unbalanced actomyosin-based pulling.
FAJs move in response to differences in local cytoskeletal geometry and pacsin2 is
recruited consistently to the trailing end of fast-moving FAJs via a mechanism that requires
an intact F-BAR domain. Photoconversion, photobleaching, immunoﬂuorescence and
super-resolution microscopy reveal polarized dynamics, and organization of junctional
proteins between the front of FAJs and their trailing ends. Interestingly, pacsin2 recruitment
inhibits internalization of the VE-cadherin complex from FAJ trailing ends and is important for
endothelial monolayer integrity. Together, these ﬁndings reveal a novel junction protective
mechanism during polarized trafﬁcking of VE-cadherin, which supports barrier maintenance
within dynamic endothelial tissue.
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T
he endothelium is a cell monolayer that covers the luminal
side of blood vessels and maintains vascular barrier
function. Regulation of endothelial monolayer integrity in
homoeostasis, as well as its remodelling during angiogenesis, and
transendothelial trafﬁcking of immune cells, occurs at the VE-
cadherin adhesion complex, the central component of endothelial
cell–cell junctions1,2. Perturbation of the tight balance between
endothelial cell–cell junction stabilization and remodelling leads
to developmental defects and vascular diseases, such as chronic
inﬂammation, oedema and atherosclerosis3–6.
To keep barrier integrity in vascular homoeostasis,
perturbations at endothelial cell–cell junctions, induced by
the highly dynamic mechanical changes that blood vessels
experience7, have to be compensated. Maintaining endothelial
cell–cell adhesion relies on the capacity of junctions to adapt to
changes in local forces they experience8. Interactions between
cells in tissue are often collectively regulated and occur via
polarized cell–cell junction dynamics9–11. For instance cells
that lead processes of collective migration, such as during
sprouting angiogenesis, generate actomyosin pulling forces and
pull along follower cells12–15. Importantly, cadherin-based
complexes are the adhesive entities that integrate these
mechanical cues from leader cells to guide follower cells16. It is
still unclear how endothelial cells maintain vascular integrity
during local differences in actomyosin–mediated pulling.
The VE-cadherin complex, which comprises the core catenins
that connect the transmembrane cadherins to the actin
cytoskeleton17,18, is regulated by mechanical forces that are
either external or induced by the actomyosin cytoskeleton19–23.
We have previously shown that actomyosin pulling forces
induce the formation of a distinct type of cell–cell junction: the
focal adherens junction (FAJ)24. FAJs are connected to radial
pulling F-actin bundles and contain the mechanotransduction
protein vinculin. Force-dependent remodelling FAJs are
prominent in monolayers of endothelial tissue cultures24, and
in the endothelium of (remodelling) blood vessels14,15,25.
Actomyosin-derived forces not only regulate the formation of
FAJs and the interaction of the VE-cadherin complex with
the actin cytoskeleton, but may also alter the plasma membrane
by inducing local membrane curvatures26. Curved membranes
are recognized and regulated by proteins that contain Bin–
Amphiphysin–Rvs (BAR) domains27–29. In the current study
we identify, using various imaging approaches, a completely
novel asymmetric signalling event at adherens junctions.
We uncover that unbalanced actomyosin activity near FAJs
provides an asymmetric signal for recruitment of the Fer-CIP4
homology-BAR (F-BAR) protein pacsin2, an inhibitor of
endocytosis30, in only one of the cells taking part in the
junction. Polarized internalization of VE-cadherin occurs
from the junctional side, where pacsin2 is recruited. We
further demonstrate that pacsin2 recruitment is important for
maintenance of cell–cell adhesion by stabilizing the VE-cadherin
complex within FAJs and inhibition of its internalization.
Results
F-BAR protein recruitment to force-dependent junctions. The
F-BAR protein pacsin2 (also known as syndapin2) is known to
regulate the actin cytoskeleton31–33 and endocytosis30,34. While
studying the role of pacsin2 in cytoskeletal remodelling during
spreading of primary human umbilical vein endothelial cells
(HUVECs)33, we observed that a subset of pacsin2 protein
localizes near cell–cell junctions. This suggested that this F-BAR
protein is involved in junction regulation. To investigate if
pacsin2 associates with the VE-cadherin complex, we performed
immunoﬂuorescence (IF) on HUVEC monolayers and stained for
endogenous pacsin2, VE-cadherin and F-actin. These IF stainings
show that pacsin2 is speciﬁcally recruited to VE-cadherin-based
FAJs, which appear as perpendicularly oriented junction
fragments between cells24, but not to stable linear adherens
junctions (Fig. 1a). IF stainings of pacsin2, VE-cadherin and
F-actin in human dermal microvascular endothelial cells
(HMEC-1 s) and human bone marrow endothelial cells
(BMEC-28 (ref. 35) corroborate these ﬁndings (Fig. 1b),
indicating that the association of pacsin2 with FAJs is
conserved in endothelial cells from different tissue origins. In
high-magniﬁcation IF images, we observed two intriguing aspects
of the pacsin2–FAJ association: ﬁrst, pacsin2 is present only at a
subset of FAJs (Fig. 1c); and second, pacsin2 does not precisely
colocalize with VE-cadherin, but concentrates asymmetrically at
one side of FAJs (Fig. 1a,b,d; Supplementary Movie 1). Moreover,
pacsin2 is recruited to FAJs of mesenchymal stromal and
epithelial cells, respectively (Fig. 1e), extending this ﬁnding to
other classical cadherin-based adhesions. To study if pacsin2
is recruited to endothelial junctions in human vasculature, we
applied IF on vessels that were isolated from healthy mesentery
sections from colon resections25. En face confocal microscopy
shows that pacsin2 is recruited to endothelial adherens
junctions in human arteries (Fig. 1f). Subsequently, we
investigated which other pacsin isoforms might be expressed in
endothelial cells. Western blot analysis shows that small amounts
of pacsin3, but not of pacsin1, are present in endothelial
cell lysates (Supplementary Fig. 1a). IF experiments further
indicate that endogenous endothelial pacsin3 is not detectable at
FAJs (Supplementary Fig. 1b), suggesting that pacsin2 is the
dominant pacsin isoform present at endothelial junctions. To
investigate if the junctional recruitment of pacsin2 is speciﬁc for
this F-BAR protein, we next analysed the distribution of nostrin,
another F-BAR protein expressed in the endothelium36, and
found that just like pacsin2, nostrin is recruited speciﬁcally to
FAJs (Fig. 1g). In contrast to the recruitment of pacsin2 to a
subset of FAJs, nostrin is recruited to almost all FAJs in HUVECs
(95.0%±2.5 s.e.m.; Fig. 1g).
FAJs are not only phenotypically distinct from stable linear
adherens junctions, but are also distinguished by the presence of
vinculin, which interacts with the VE-cadherin–a-catenin
complex upon force-induced tension23,24. To investigate the
association of pacsin2 and vinculin with VE-cadherin at FAJs, we
performed triple IF stainings. These experiments clearly show
that pacsin2 and vinculin are both speciﬁcally present at FAJs
(Fig. 1h). However, we observed that pacsin2 was recruited to the
VE-cadherin–vinculin complex only at a fraction of FAJs
(Fig. 1c,h), whereas vinculin is present at all FAJs24. Moreover,
vinculin distribution at FAJs compares to that of VE-cadherin,
whereas pacsin2 is asymmetrically present at one side of FAJs
(Fig. 1d). These data argue against a direct force-induced
molecular interaction of pacsin2 with the VE-cadherin–a-
catenin complex itself, but indicate that pacsin2 is recruited to
FAJs via a different mechanism. Because the F-BAR protein
nostrin is recruited to FAJs as well, we propose that speciﬁc
membrane curvature at FAJs recruits pacsin2. Together, these
data reveal that F-BAR proteins are recruited to force-dependent
remodelling junctions in vascular endothelium, as well as in other
cell types that form cell–cell adhesions via classical cadherins.
Unbalanced actomyosin activity at FAJs recruits pacsin2. To
understand how pacsin2 is recruited to cell–cell junctions, we ﬁrst
investigated the formation of FAJs by increasing cytoskeletal-
derived tension on junctions, following thrombin treatments as
described previously24. Strikingly, during the formation of FAJs
by thrombin, we observed a decrease in the fraction of pacsin2-
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positive FAJs compared with control monolayers (Fig. 2;
Supplementary Movie 2). Inhibition of cytoskeletal tension by
using the Rho-kinase inhibitor Y-27632 also resulted in
signiﬁcantly fewer pacsin2-positive FAJs (Fig. 2; Supplementary
Movie 3). These results suggest that the universal increases or
decreases in tension on junctions in monolayers do not trigger
pacsin2 recruitment. Next, we investigated pacsin2 recruitment to
FAJs during polarized cell migration in scratch wound assays. IF
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stainings of control and scratch-wounded monolayers show that
the polarized migration induces pacsin2 recruitment
preferentially to the rear of FAJs compared with
the direction of wound closure (Fig. 3a; the fraction of
pacsin2-positive FAJs that recruited pacsin2 to the side opposite
from the migration direction is 76.5%±3.95 s.e.m.).
Subsequently, we investigated the level of actomyosin activity
near pacsin2-positive FAJs. IF stainings for active myosin-II
(myosin light chain phosphorylated on the Ser19 residue;
pMLC-Ser19) showed that the near junctional distribution ratio
of pMLC-Ser19 is unbalanced between cells sharing pacsin2-
positive FAJs (Fig. 3b). The average ratio between pMLC-Ser19
intensity at the pacsin2-negative side and the intensity at the
opposite side is 2.46±0.34 s.e.m. Thus, pacsin2 is recruited to
the FAJ side opposite from the highest myosin-II-based pulling
activity (Fig. 3b). These results indicate that differences in the
geometry of the near junctional actomyosin network between
cells relates to pacsin2 recruitment. The local organization
of actomyosin at junctions is tightly controlled by the activation
of small GTPases37–39. To study if forcing the actin cytoskeleton
into an asymmetric geometry near FAJs directly regulates pacsin2
recruitment, we ectopically expressed an activated mutant of the
GTPase Rac1 (Rac1[Q61L]) in HUVECs, and analysed their FAJs
formed with untransfected cells in mosaic cultures. We ﬁnd that
pacsin2 is preferentially recruited to the FAJ side of cells
expressing activated Rac1 (Fig. 3c), whereas pacsin2 recruitment
in cells ectopically expressing wild-type Rac1 does not localize at a
preferred FAJ side (Fig. 3c). Together, these data show that local
asymmetric organization of the actomyosin cytoskeleton induces
pacsin2 recruitment to FAJs.
We next addressed the mechanism that underlies the asym-
metric presence of pacsin2 at junctions. A curve of the double
membrane at AJs is intracellularly perceived both as convex and
concave shapes, depending from which cellular side of the junction
this is sensed. To investigate if the recruitment of pacsin2, known
to interact with convex membranes33,40, to FAJs is derived from
one or both cells forming the junction, we monitored dynamics of
mosaic endothelial monolayers, in which half the cell population
expresses lentivirally transduced pacsin2-green ﬂuorescent
protein (GFP) and the other half pacsin2-mCherry. These
studies show that the presence of pacsin2 at FAJs is either GFP
or mCherry ﬂuorescent (Fig. 3d; Supplementary Movie 4),
indicating that pacsin2 recruitment to junctions occurs from one
side of the cell–cell junction.
Pacsin2, like many other F-BAR proteins, contains an F-BAR
domain that is crucial for its binding to phospholipids in curved
membranes and an SH3 domain, which interacts with effector
proteins27. To further characterize its junctional recruitment
mechanism, we expressed pacsin2 variants in HUVECs. We ﬁrst
tested if the pacsin2 F-BAR domain is involved in its asymmetric
recruitment to FAJs. We expressed a GFP-tagged pacsin2-R50D
mutant, which can no longer recognize convex membrane
curvature, and a double mutant pacsin2[M124,125E], which
cannot induce membrane tubulation33,40, in HUVECs. In
particular the pacsin2[R50D] mutant is no longer concentrated
at FAJs (Fig. 4a). Next, we expressed a truncated variant of
pacsin2 (pacsin2-D306), which contains the complete F-BAR
domain, but lacks Asn-Pro-Phe (NPF) motifs and the SH3
domain. Also pacsin2-D306 protein is signiﬁcantly perturbed
in its capacity to concentrate at FAJs. Finally, expression of an
SH3-domain-mutated pacsin2[P478L] did not affect
concentration of pacsin2 at FAJs (Fig. 4a). These results
indicate that the pacsin2 F-BAR domain is crucial, but not
sufﬁcient, for its recruitment to FAJs.
To assess pacsin2 recruitment in relation to FAJ remodelling,
we performed live imaging of HUVECs with lentiviral expression
of pacsin2-GFP and a-catenin-mCherry (as marker for adherens
junctions). Imaging of these transduced cells indicates that
when pulling activity between cells is unbalanced, FAJs
themselves displace in the direction of the cell that pulls away.
This provides FAJs with a front (that is, the junction side of
increased pulling) and a trailing end that follows the movement of
the FAJ. Pacsin2 is consistently recruited to FAJ trailing
ends (Fig. 4b; Supplementary Movies 4 and 5). We conﬁrmed
these ﬁndings in live cell imaging experiments of HUVECs
expressing VE-cadherin-GFP and pacsin2-mCherry, or
pacsin2-GFP and p120-catenin-mCherry (Supplementary
Movies 6 and 7). These experiments also show that pacsin2
recruitment is highly dynamic; its presence at junctions is not
constitutive, but relates to the movement of FAJs during
unbalanced remodelling. We ﬁnd that the increased speed of
FAJ movement signiﬁcantly correlates with a higher concentra-
tion of pacsin2 at FAJs (Fig. 4b). Moreover, live imaging of cells
expressing pacsin2[R50D]-GFP and a-catenin-mCherry conﬁrms
that a functional F-BAR domain is crucial for the recruitment of
pacsin2 to fast-moving FAJs (Supplementary Movie 8).
Taken together, these data show that asymmetric remodelling
of FAJs, mediated by local actomyosin changes, induces
pacsin2 recruitment to the trailing ends of FAJs in an F-BAR
domain-dependent manner.
Association of pacsin2 with VE-cadherin at super-resolution.
Because (i) recruitment of pacsin2 to FAJs occurs via a different
mechanism than recruitment of vinculin, and (ii) pacsin2
recruitment depends on a functional F-BAR domain, which is
Figure 1 | F-BAR protein recruitment to force-remodelling adherens junctions. (a) Wideﬁeld immunoﬂuorescence (IF) images of HUVECs stained for
pacsin2 (green), F-actin (red) and VE-cadherin (blue). Magniﬁed images of regions of interest at focal adherens junctions (FAJs) and linear adherens
junctions (LAJs). Arrows indicate pacsin2-positive FAJs. Graph shows the average ratio±s.e. of the mean (s.e.m.) between pacsin2 and VE-cadherin
ﬂuorescence integrated intensities along junctional linescans. n¼44 FAJs; n¼ 36 LAJs from three independent experiments. (b) Wideﬁeld IF images of
FAJs in HMEC-1 and BMEC-28 monolayers stained for pacsin2 (green), F-actin (red) and VE-cadherin (blue). (c) Graph shows a quantiﬁcation of the
percentage±s.e.m. of FAJs that are pacsin2-positive in IF images of HUVEC (n¼ 22 images), HMEC-1 (n¼ 16 images) or BMEC-28 cells (n¼ 30 images)
from nZ2 independent experiments. (d) Graph shows the average distribution±s.e.m. of VE-cadherin, pacsin2 and vinculin intensities along
pacsin2-positive FAJs. A ratio of 1 represents symmetric distribution along FAJs. For VE-cadherin and pacsin2, the analysis was from n¼40 FAJs, and for
vinculin n¼ 27 FAJs from nZ2 independent experiments. (e) Wideﬁeld IF images of FAJs in mesenchymal stromal cells (MSC) stained for pacsin2 (green),
F-actin (red) and N-cadherin (blue); and prostate epithelial cells (DU145) stained for pacsin2 (green), F-actin (red) and b-catenin (blue). (f) En face
confocal IF images of human mesenteric artery stained for VE-cadherin (red) and pacsin2 (green). (g) Wideﬁeld IF images of FAJs in HUVEC monolayer
stained for nostrin (green), F-actin (red) and VE-cadherin (blue). First graph shows the average ratio±s.e.m. between nostrin and VE-cadherin
ﬂuorescence integrated intensities along junctional linescans. n¼ 33 FAJs; n¼ 31 LAJs from three independent experiments. The second graph shows the
average percentage±s.e.m. of FAJs that are nostrin positive (n¼ 12 HUVEC images from three independent experiments). (h) Wideﬁeld IF images of FAJs
in HUVECs stained for pacsin2 (green), vinculin (red) and VE-cadherin (blue). Linescan analysis along the white dotted line shows the ﬂuorescence
intensities of VE-cadherin (right y axis), vinculin and pacsin2 signals (left y axis). **Pr0.01 (Student’s t-test).
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known to interact with the plasma membrane, we next used
stimulated emission depletion (STED) super-resolution
microscopy to further dissect the molecular organization of FAJs.
First, we analysed the colocalization of endogenous VE-cadherin
with the core catenin proteins in STED images and, as expected,
found a high Pearson’s correlation coefﬁcient (R) of these pro-
teins with VE-cadherin at FAJs: a-catenin (R¼ 0.72), b-catenin
(R¼ 0.77) and p120-catenin (R¼ 0.64; Fig. 5a,b). Localization of
vinculin also correlates well with that of VE-cadherin at this
resolution (R¼ 0.53). By contrast, pacsin2 molecules show a
signiﬁcantly lower correlation with VE-cadherin (R¼ 0.16) and
the super-resolution imaging reveals that pacsin2 is decorating
the invaginating ends of FAJs (Fig. 5a,b). This detailed structure is
not discernible in lower optic resolution imaging such as by
conventional wideﬁeld (for example, Fig. 1a) or confocal imaging
(Fig. 5a). Thus, the super-resolution imaging revealed that
pacsin2 is not part of the VE-cadherin complex, but decorates
around the VE-cadherin-based adhesion structure instead,
suggesting this may be the location of curved membranes at
asymmetric remodelling FAJs.
Polarized dynamics of VE-cadherin at asymmetric FAJs. The
previous experiments suggest the existence of a mechanism for
polarized regulation of AJs in response to unbalanced cytoskeletal
pulling between cells. The recruitment of pacsin2 associates with
this polarization. To understand the consequences of asymmetric
regulation of VE-cadherin-based junctions, we ﬁrst expressed and
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visualized a fusion of a-catenin with the Dendra2 green-to-red
photoswitchable ﬂuorescent protein. Next, we photoswitched
a-catenin-Dendra2 at the front of asymmetric FAJs. These
experiments show that a-catenin molecules photoconverted to
Dendra2-red at the front of FAJs move to the trailing ends of
FAJs over time (Fig. 6a; Supplementary Movie 9). To investigate if
there is differential mobility of junctional proteins in distinct
parts of FAJs, we next performed ﬂuorescence-recovery-
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after-photobleaching (FRAP) experiments of a-catenin-mCherry
at pacsin2-positive FAJs. We compared a-catenin recovery at the
front of pacsin2-positive FAJs, to its recovery at the trailing ends.
Whereas ﬂuorescence intensity of a-catenin-mCherry at the front
of junctions readily recovers after bleaching, we ﬁnd a marked
reduction in the recovery of a-catenin at the side of FAJs
that recruited pacsin2 (Fig. 6b,c; Supplementary Movie 10). To
quantify these results, we determined the average ﬂuorescence
intensity values (corrected for overall bleaching and normalized
to ﬂuorescence intensity before (100%) and after (0%) bleaching)
of multiple FRAP experiments. These data indicate that the
mean mobile fraction of a-catenin-mCherry at the front of
pacsin2-positive FAJs (65.5%±4.2 s.e.m.) is signiﬁcantly higher
than at their trailing ends (38.1%± 4.9 s.e.m.; Fig. 6d). In
contrast, the average ﬂuorescence recovery of a-catenin-mCherry
at the front and trailing ends of pacsin2-negative FAJs is
comparable (Fig. 6c,d). These data reveal a correlation between
pacsin2 recruitment and local stabilization of a-catenin at the
trailing ends of polarized FAJs. This is consistent with an
inhibitory role of pacsin2 in endocytosis30. We further conclude
that pacsin2 demarcates the junction side that is lacking nascent
formation of VE-cadherin-based adhesions.
Pacsin2 and asymmetric internalization of VE-cadherin. To
understand the dynamics of VE-cadherin at the trailing ends of
FAJs, we further investigated endogenous VE-cadherin and
pacsin2 proteins in HUVEC, HMEC-1 and BMEC-28
monolayers. Since there is differential mobility of a-catenin, a
crucial element of the VE-cadherin complex, between the front
and trailing ends of pacsin2-positive FAJs, and because pacsin2 is
known to inhibit internalization from the plasma membrane30,
we next analysed the ﬂuorescence intensities of VE-cadherin and
pacsin2 across individual FAJs. Linescan analysis demonstrates
that pacsin2 recruitment at the trailing ends of FAJs marks the
junctional border, where the level of VE-cadherin protein declines
(Fig. 7a), corresponding with their asymmetric difference in
distribution along FAJs (Fig. 1d). To assess whether FAJ trailing
ends are sites where VE-cadherin is being internalized, we
live-labelled HUVEC monolayers with an Alexa-Fluor-647-
conjugated non-blocking anti-extracellular VE-cadherin
antibody (mouse monoclonal 55/7H1 (ref. 41). Two hours
after the labelling, cells were ﬁxed and stained for the surface
VE-cadherin pool with another anti-extracellular VE-cadherin
antibody (monoclonal 75; distinct ﬂuorescence wavelength). IF
images of these cells show that the pre-labelled VE-cadherin pool
(representing those molecules that were on the surface 2 h
before ﬁxation) is concentrated at FAJ trailing ends (Fig. 7b).
Under these conditions, the staining with clone 75 antibody was
higher at FAJ fronts, suggesting that a signiﬁcant portion of the
VE-cadherin molecules is internalized from the cell surface at FAJ
trailing ends (Fig. 7b). To investigate if pacsin2 recruitment
correlates to the side of FAJs, where the majority of pre-labelled
VE-cadherin molecules locate, we performed IF experiments in
which pre-labelled surface VE-cadherin stainings were followed
by permeabilization and stainings for pacsin2. These images show
higher intensities of pre-labelled VE-cadherin than the surface
pool of VE-cadherin at the pacsin2-positive trailing ends of
FAJs (Fig. 7c). Of note, we noticed even more enrichment
of pre-labelled VE-cadherin molecules at the trailing ends of
pacsin2-negative FAJs (Fig. 7c). This is consistent with a
stabilizing effect of pacsin2 on the mobility of a catenin at
the trailing ends of FAJs (Fig. 6d). Live imaging of HUVECs
expressing pacsin2-GFP and a-catenin-mCherry further reveals
that in some cases pacsin2 is recruited before internalization
events from the trailing ends of FAJs. Internalization from those
FAJs is promoted once pacsin2 dissociates from the junction
(Fig. 8a; Supplementary Movie 11). Taken together these data
indicate that pacsin2 is recruited to the internalization side of
FAJs and that the presence of pacsin2 at FAJs correlates with
suppressed levels of internalized VE-cadherin compared with
pacsin2-negative FAJs.
To investigate the subcellular compartments to which
internalized VE-cadherin is trafﬁcked, we analysed the
localization of surface-chased VE-cadherin molecules. We ﬁnd
that surface-chased VE-cadherin molecules culminate in Rab5
GTPase-positive endosomes (Fig. 8b,g), in line with other
recent studies which show that endocytosis directs VE-cadherin
to early endosomes42,43. Moreover, we ﬁnd that a fraction
(43%±2 s.e.m.) of surface-chased VE-cadherin is contained in
Rab4-positive endosomes (Fig. 8c,g), but not in Rab11 recycling
endosomes (Fig. 8d,g). The presence of VE-cadherin in
Rab4-positive vesicles was conﬁrmed in IF stainings for total
endogenous VE-cadherin (Fig. 8e,g). Moreover, live cell imaging
of VE-cadherin-red ﬂuorescent protein (RFP) and Rab4-GFP
shows that internalized VE-cadherin molecules that derive from
the trailing ends of FAJs are directed towards Rab4-positive
vesicles (Supplementary Movie 12). Colocalization analysis of
surface-chased VE-cadherin molecules with the vascular
endothelial growth factor receptor 2, known as cargo of
recycling endothelial vesicles44, conﬁrmed that VE-cadherin is
targeted to an endosomal recycling compartment (Fig. 8f,g).
We next investigated what portion of internalized VE-cadherin
molecules is intrinsically endocytosed, or alternatively, might be
exo-endocytosed from neighbouring cells43,45. VE-cadherin-GFP
was expressed in a sparse fraction of endothelial cells (donor cells)
and VE-cadherin internalization in neighbouring adhered
non-transduced cells (acceptor cells) was monitored.
Subsequently, we surface-chased VE-cadherin for 2 h using
Alexa-647-labelled 55/7H1 antibody and determined the
number of GFPþ /Alexa647þ versus GFP-/Alexa647þ
vesicles in acceptor cells. These experiments show that 81%
Figure 3 | Asymmetric actomyosin organization between cells recruits pacsin2 to FAJs. (a) Wideﬁeld IF images of polarized migrating HUVECs in a
scratch-wound assay that are stained for pacsin2 (green), F-actin (red) and VE-cadherin (blue). Arrows indicate the presence of pacsin2 at the rear ends of
FAJs. Dotted line represents the leading front of the wound-closing HUVECs. The lower panels represent enlargements of three regions of interests from
the merge image. Graph shows the average fraction from pacsin2-positive FAJs that are orientated in the indicated degree in relation to the scratch wound
in IF images taken 4 h after wounding or in relation to the bottom (180) of images of control monolayers. Analysis was performed on four independent
experiments and included4250 junctions per experiment. (b) Confocal IF images of FAJs in HUVECs stained for pacsin2 (green), p-MLC Ser19 (red) and
VE-cadherin (blue). Graph shows the average local integrated ﬂuorescence intensity±s.e.m. of p-MLC Ser19 at the near junctional area at the pacsin2-
positive versus pacsin2-negative side of FAJs. n¼41 FAJs analysed from three independent experiments. (c) Wideﬁeld IF images of mosaic cultured
HUVECs which are non-transfected or transfected with Rac1[Q61]-mCherry or wild-type Rac1-mCherry (red). Cells are stained for pacsin2 (green), F-actin
(grey) and VE-cadherin (blue). Graph shows the average number of Pacsin2-positive FAJs in the transfected cells (intrinsic pacsin2) or in the neighbouring
cells (extrinsic pacsin2). n¼ 34 Rac[Q61L]-transfected cells and n¼ 26 Rac1 wild-type-transfected cells from two independent experiments. Arrows
indicate pacsin2-positive FAJs. (d) Wideﬁeld time-lapse images of mosaic FAJs between HUVECs with lentiviral expression of pacsin2-GFP (green) or
pacsin2-mCherry (red). See also Supplementary Movie 4. **Pr0.01 (Student’s t-test).
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms12210 ARTICLE
NATURE COMMUNICATIONS | 7:12210 |DOI: 10.1038/ncomms12210 | www.nature.com/naturecommunications 7
bPacsin2-
GFP
α-Catenin-
mCherry
Merge
Direction of
movement
Live cell imaging (time = min)
10 μm
Recruited pacsin2
R
at
io
 o
f ju
nc
tio
na
l
pa
cs
in
2/
VE
C 
in
te
ns
itie
s
Pa
cs
in
2-
G
FP
Pa
cs
in
2 
(R
50
D)
-G
FP
Pa
cs
in
2 
(M
12
4,1
25
E)
-G
FP
Pa
cs
in
2-
Δ3
06
-G
FP
Pa
cs
in
2 
(P
47
8L
)-G
FP
a
Pacsin2-GFP VE-cadherin Merge
W
T
R
50
D
M
12
4,
12
5E
Δ3
06
P4
78
L
10 μm
10 μm
10 μm
10 μm
10 μm
0.0
0.2
0.4
0.6
0.8
1.0
1,000
< 0.3 μm min–1
0
250
500
750
Av
g.
 
jun
cti
on
al
pa
cs
in
2 
in
te
ns
ity
> 0.3 μm min–1
Speed of FAJ
movement
4,500
3,500
1,500
2,500
500
0.3 0.6 0.9 1.2 1.50
–500
Speed of FAJ
movement (μm min–1)
R
el
. ju
nc
tio
na
l
pa
cs
in
2 
in
te
ns
ity
**
*
**
Avg speed
r2 = 0.08
00:00
10:00
50:00
Figure 4 | Pacsin2 is recruited to the trailing ends of fast-moving FAJs in an F-BAR domain-dependent manner. (a) Wideﬁeld IF images of HUVECs
expressing indicated variants of pacsin2-GFP (green) that are stained for endogenous VE-cadherin (red). Graph shows the average ratio±s.e.m. between
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time-lapse images of FAJs in HUVECs expressing pacsin2-GFP (green) and a-catenin-mCherry (red). White arrows indicate pacsin2 at junctions, grey
arrowheads indicate the displacement direction of FAJs. Note that pacsin2 is recruited to the trailing ends of remodelling FAJs. See corresponding
Supplementary Movie 5 for aB60min time-lapse recording. See also Supplementary Movies 6–8. Scatter plot shows a quantiﬁcation of the speed of FAJ
movement in relation to the relative integrated ﬂuorescence intensity of pacsin2-GFP from linescans along FAJs. The average speed of all analysed FAJs is
0.3mmmin 1. The bar graph is based on the same data set and shows the average junctional pacsin2 intensity at FAJs that move slower than
0.3mmmin 1 (n¼ 109 FAJ tracks) or faster than 0.3mmmin 1 (n¼ 56 FAJ tracks) from a total of nine independent time-lapse recordings. *Pr0.05;
**Pr0.01 (Student’s t-test).
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(±11.3 s.e.m.) of the internalized VE-cadherin-positive vesicles
are endocytosed, whereas 9% (±1.4 s.e.m.) of the internalized
vesicles were transferred from adjacent VE-cadherin expressing
cells (Fig. 8h). Taken together, these data demonstrate that
the VE-cadherin complex is internalized from asymmetric
remodelling FAJs and transported to endosomal compartments.
Pacsin2 controls VE-cadherin and endothelial barrier. To
assess the role of pacsin2 in endothelial cell–cell adhesion, we
next performed knockdown of pacsin2 protein expression by
lentiviral expression of short hairpin RNAs (shRNAs). Two of the
ﬁve tested shRNA constructs induced robust pacsin2 knockdown
in HUVECs (Supplementary Fig. 2a). We detected no changes in
total VE-cadherin protein levels in lysates of HUVECs depleted
for pacsin2 (Fig. 9a) nor on total surface levels of VE-cadherin as
determined by ﬂuorescence-activated cell sorting (FACS; Fig. 9b).
IF imaging showed that shPacsin2 knockdown cells still form
VE-cadherin-based adherens junctions, including FAJs, as well as
tight junctions, and we did not observe major phenotypic changes
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of endothelial monolayers (Fig. 9c; Supplementary Fig. 2b).
To address whether pacsin2 controls VE-cadherin internalization,
we ﬁrst compared the fate of surface-chased VE-cadherin
between shControl and shPacsin2 cells. These experiments
clearly show that in the absence of pacsin2, increased levels of
surface-chased VE-cadherin accumulate in internalized vesicles
(Fig. 9d). Internalization of VE-cadherin is associated with the
appearance of a 100 kDa fragment of VE-cadherin46. Western
blot analysis of VE-cadherin in lysates of shControl or shPacsin2
transduced HUVECs indicate an increased quantity of the
100 kDa fragment in the absence of pacsin2 (Fig. 9e). Together
these experiments evidently demonstrate that pacsin2 inhibits
internalization of the VE-cadherin complex.
To investigate whether pacsin2 has a role in the polarized
trafﬁcking of a-catenin at FAJs, we next studied the mobility of
a-catenin-mCherry at the trailing end of FAJs by FRAP in
shControl and shPacsin2 transduced HUVECs. We ﬁnd that the
average mobile fraction of a-catenin-mCherry at the trailing end
of FAJs is signiﬁcantly higher in shPacsin2 HUVECs (51%±3.5
s.e.m.) than in shControl HUVECs (35%±1.6 s.e.m.; Fig. 9f).
These experiments indicate that pacsin2 controls the polarized
trafﬁcking of the VE-cadherin complex at FAJs.
To functionally investigate the role of pacsin2 in endothelial
cell–cell junctions, we analysed barrier function by measuring
endothelial resistance using electric cell–substrate impedance
sensing (ECIS) across endothelial cells transduced with pacsin2 or
control shRNA. These experiments show that shPacsin2 cells
have a signiﬁcantly reduced capacity to form endothelial barriers,
which is apparent both during cell–cell junction formation
between recently plated cells and within established monolayers
(4 and 16 h after seeding, respectively; Fig. 9g). To investigate
which domains of pacsin2 are important for its barrier protective
function, we knocked down pacsin2 in HUVECs expression by
means of an shRNA targeting the 30-untranslated region (UTR)
of the endogenous pacsin2 messenger RNA (the shPacsin2
30-UTR plasmid also contains a TagRFP complementary DNA).
In parallel, we re-expressed GFP-tagged pacsin2, pacsin2[R50D]
or pacsin2[P478L]. After transduction and puromycin selection,
cells were sorted by FACS for dual GFP and TagRFP positivity.
Western blot analysis shows efﬁcient knockdown of endogenous
pacsin2 and expression of the rescue constructs (Fig. 9h). Next,
we investigated the capacity of these cell types to form an
endothelial barrier using ECIS. These experiments conﬁrm that
pacsin2 is needed for efﬁcient junction formation. Rescuing the
shPacsin2 30-UTR expressing cells with pacsin2-GFP signiﬁcantly
restores the barrier forming capacity, whereas expressing the
pacsin2[R50D] mutant, which fails to concentrate at FAJs
(Fig. 4a), does not mediate this effect (Fig. 9i). Expression of
the pacsin2[P478L] mutant, which does become recruited to FAJs
(Fig. 4a), rescues the barrier formation to a certain extent (Fig. 9i).
Taken together, these data indicate that pacsin2 is required for
efﬁcient barrier formation and stabilization in an F-BAR domain
dependent manner. The data point towards a protective role for
F-BAR proteins during asymmetric remodelling of endothelial
junctions in vascular barrier maintenance.
Discussion
Many recent studies underscore the importance of the activity and
organization of the actomyosin cytoskeleton for endothelial
cell–cell junction dynamics (reviewed in ref. 47). The regulation
of junctions is crucial for development and immune surveillance,
and its involvement in vascular disease is unmistakable. This study
provides evidence for a novel mechanism of protection against
asymmetric internalization of the VE-cadherin complex that
follows unbalanced force-induced junction remodelling and is
important for endothelial barrier function. Our data show that
upon imbalanced pulling activity between cells (that is, when one
cell pulls stronger than the other), the cell–cell junctions adopt an
asymmetric geometry with a junction front where new VE-
cadherin complex adhesions are formed, and a trailing end from
which the VE-cadherin complex is internalized. We demonstrate
that pacsin2, which is recruited to the trailing ends of a subset of
FAJs, is important to maintain cell–cell adhesion during their rapid
asymmetric remodelling (Fig. 10).
We identify the F-BAR protein pacsin2 as a novel regulator of
endothelial cell–cell adhesion. Its recruitment to, and function at,
FAJs involves its speciﬁc ability to recognize convex membrane
curvature40. A potential alternative mechanism for its
recruitment to junctions is via speciﬁc conformations of the
F-actin cytoskeleton that is distinctive at FAJs48, and might
enable a direct interaction of F-actin with the pacsin2 F-BAR
domain31. Our super-resolution studies revealed that pacsin2 is
covering around the trailing ends of FAJs and is not precisely
colocalizing with the F-actin-binding proteins a-catenin and
vinculin, which favors a model in which plasma membrane
curves recruit pacsin2 to FAJs.
We ﬁnd that pacsin2 is recruited to a subset of polarized
junctions, where internalization takes place. The comparison of
VE-cadherin internalization in shControl and shPacsin2
transduced cells clearly show that once pacsin2 is functionally
perturbed, there are increased levels of overall internalized
VE-cadherin. This increase in internalization of VE-cadherin is
associated with a decreased endothelial barrier capacity, which
Figure 6 | Polarized protein dynamics within asymmetric FAJs. (a) Time-lapse images of HUVECs expressing a-catenin-Dendra2 before and after
photoswitching at the front of an FAJ using a 405-nm confocal laser. Newly recruited a-catenin protein (green) appears at the front of FAJs, whereas
a-catenin-Dendra2 photoswitched to red moves to the trailing end of the FAJ (followed by the arrows). See corresponding Supplementary Movie 9 for a
B12min time-lapse recording. Line graph shows the average distribution±s.e.m. of photoconverted a-catenin-Dendra-red along FAJs in time. Symmetric
ratio analysis was performed by splitting the integrated ﬂuorescence intensities along linescans that span FAJs into two halves. A ratio 41 means
concentration of a-catenin-Dendra-red at the FAJ front, a ratio of 1 means symmetric distribution along the FAJ, and o1 means concentration at the FAJ
trailing end. n¼ 5 independent Dendra photoswitching experiments. (b) Time-lapse images of HUVECs expressing pacsin2-GFP and a-catenin-mCherry
showing mCherry ﬂuorescence signal before and after photobleaching using a 561-nm confocal-laser to investigate protein dynamics at the front and at the
trailing end of FAJs. Merged images at the bottom show pacsin2-GFP and a-catenin-mCherry localization of FAJs after the FRAP experiment. See
corresponding Supplementary Movie 10 for a B200 s time-lapse recording. (c) Left graph shows the average recovery±s.e.m. of a-catenin-mCherry
ﬂuorescence signal as a percentage of the signal before bleaching at the front (12 independent FRAP experiments) or trailing end of pacsin2-positive FAJs
(9 independent FRAP experiments). Right graph shows the quantiﬁcation of similar FRAP experiments at pacsin2-negative FAJs (front, 16 independent
experiments; trailing end, 12 independent experiments). (d) Bar graph shows the average±s.e.m. recovered mobile fraction of a-catenin-mCherry
ﬂuorescence signal at the front and trailing ends of pacsin2-positive and pacsin2-negative FAJs (based on the data of c). For pacsin2-negative FAJs, the
junctional orientation was determined by the direction of observed junctional movement (n¼ 16 independent experiments per junction side).
The percentage of recovery was determined by calculating the average recovery in the plateau phase of the FRAP curves between 100 and 125 s after
bleaching. **P-valuer0.01, NS, not signiﬁcant (Student’s t-test).
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corresponds with the notion that VE-cadherin-based adherens
junctions are crucial for endothelial barrier function. The FRAP
experiments comparing pacsin2-positive and pacsin2-negative
FAJs indicate that once recruited to the trailing ends of
FAJs, pacsin2 locally stabilizes a-catenin. This may explain the
protective role of pacsin2 during junction internalization and
endothelial barrier function. Others previously reported that the
presence of pacsin2 at the plasma membrane inversely correlates
with the recruitment of dynamin 2, a protein that mediates
membrane scission49. Possibly, a similar competing mechanism
with dynamin is responsible for the inhibitory role pacsin2 has
during VE-cadherin internalization from FAJs.
Our data shows that pacsin2 is not essential for the polarized
movement of VE-cadherin molecules along FAJs or their
internalization. This is visible, for example, in Supplementary
Movie 11, which captured the internalization process from FAJs.
Pacsin2 is not continuously covering the FAJ and internalization
from that FAJ is promoted once pacsin2 dissociates from the
junction trailing end. In fact, in cells where pacsin2 is functionally
perturbed by shRNAs, VE-cadherin internalization is strongly
enhanced. Importantly, when we observe junctional recruitment
of pacsin2 we consistently ﬁnd it at the trailing end, where the
internalization of VE-cadherin molecules occurs, and not at the
FAJ front where new cell–cell adhesion complexes are being
formed. Because we ﬁnd a correlation between increased pacsin2
recruitment during the moments of faster polarized FAJ
movements, we speculate that the pacsin2 negative, but polarized
junctions, might have been pacsin2 positive earlier in their
lifetime. Taken together, the data suggest that pacsin2 inhibits
VE-cadherin internalization from those faster moving FAJs.
Because pacsin2 is ubiquitously expressed30,34, and we detect it
also at E-cadherin- and N-cadherin-based-FAJs, we surmise that
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pacsin2 serves similar functions in other cell types that form
classical cadherin-based cell–cell junctions. Recently, in
Caenorhabditis elegans, the F-BAR protein SRGP-1 (an srGAP
orthologue) was shown to regulate membrane dynamics during
cell–cell junction formation, and its function is needed for
efﬁcient cadherin-based cell–cell adhesion50. Two other F-BAR
proteins have been implicated in regulating cell–cell adhesion in
Drosophila; the F-BAR proteins CIP4 and nostrin also appear to
function as cadherin internalization suppressors51, which
resembles the protective function of pacsin2 on internalization
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of the VE-cadherin complex. Of note, it is not yet clear whether
these other F-BAR proteins are speciﬁcally recruited to certain
cell–cell junction conformations, or whether they are controlled
by actomyosin activity in these model systems. In epithelial
cell types, depletion of junctional CIP4 impaired E-cadherin
trafﬁcking, and inhibited EGF-induced cell scattering and
invasion of epithelial cancer cells52. Moreover, increased CIP4
protein expression levels were associated with the increased
tensile adherens junctions and invasiveness of human breast
cancer52. Together with our experiments, these data point
towards tailored mechanisms regulating endothelial and
epithelial cell–cell junctions by F-BAR proteins. Intriguingly, we
ﬁnd that nostrin is present at almost all endothelial FAJs, whereas
pacsin2 is present at a subset of FAJs. There could be various
reasons for this difference: there might be distinct expression
levels of nostrin and pacsin2, the presence of pacsin2 at FAJs
might be more transient than nostrin’s or another possibility is
that the degree of curvature of the F-BAR dimers is slightly
different and there are more FAJs that ﬁt the structure of nostrin.
Even so, both F-BAR proteins are preferentially recruited to
FAJs, and not to linear adherens junctions, which suggests that
the membrane at FAJs adopts speciﬁc conformations that are
recognized by these F-BAR proteins.
One of the key events implicated in inﬂammation, as well as in
mechanical-induced remodelling of cell–cell junctions, is the
trafﬁcking of the VE-cadherin complex. Internalization of VE-
cadherin occurs in response to permeability factors (for example,
vascular endothelial growth factor and bradykinin), actomyosin
contraction, changes in (hemodynamic) forces or transendothelial
migration of immune cells43,53–55. Because we ﬁnd that in the
absence of pacsin2 the overall internalization of the VE-cadherin
complex is increased, and endothelial barrier function is perturbed,
we propose that pacsin2 recruitment is part of a signalling pathway
that protects junctions during asymmetric dynamic events. Tensile
adherens junctions are essential structures that orchestrate
collective behaviour of cells in a monolayer56, and polarized
internalization and recycling of cadherin-based adhesions
underlies this phenomenon9. Polarized trafﬁcking at endothelial
junctions likely feeds into pathways that determine the ability of
endothelial cells to adapt to the rapid changes in adhesion, pulling
forces and repulsive cues57. Although, we observe that VE-
cadherin molecules internalized from FAJs are ending up in Rab4-
positive vesicles, it remains to be addressed whether pacsin2 has
also a direct role in trafﬁcking towards recycling compartments
that functionally take part in newly forming cell–cell adhesions.
Methods
Cells and tissue. Pooled HUVECs (cultured up to passage six) from different
donors (purchased from Lonza), immortalized HMEC-1 (described in ref. 58) and
human BMEC-28 (described in ref. 35) were cultured in EBM-2 culture medium
supplemented with EGM-2 BulletKit (Lonza) on gelatin-coated tissue ﬂasks.
HEK293T, HeLa and epithelial DU145 cells (purchased from American Type
Culture Collection (ATCC)) were cultured in Iscove’s modiﬁed Dulbecco’s
medium with L-glutamine (Lonza) supplemented with 10% fetal calf serum and
antibiotics. Bone marrow-derived human mesenchymal stromal cells, a kind gift
from Dr Carlijn Voermans, were isolated and cultured as described previously59.
Human blood vessels were isolated from tissue that remains after pathology
analysis of mesentery from patients that underwent intestinal tumour resection in
the Academic Medical Center (Dr Mat Daemen, Amsterdam, The Netherlands) as
described previously25. All vessels were obtained with informed consent and
according to the Dutch guidelines for secondary used patient material.
DNA constructs and lentiviral transductions. For lentiviral transductions,
human pacsin2 fused at its C terminus to a GFP tag was ampliﬁed by PCR from a
pcDNA6.2/C-EmGFP-DEST-pacsin2 vector (provided by Dr Ronen Zaidel-Bar)
and cloned into a self-inactivating lentiviral pLV-CMV-ires-puro vector between
the SnaBI and NheI restriction sites to generate pLV-CMV-pacsin2-GFP, and the
pLV-CMV-pacsin2-D306 variant that expresses only its F-BAR domain: amino
acids 1–306. The pLV-CMV-pacsin2-GFP construct was modiﬁed by replacing
GFP with mCherry DNA sequence to generate pLV-CMV-pacsin2-mCherry. An
arginine (CGC) to aspartic acid (GAC) mutation at amino acid position 50 in the
pacsin2 F-BAR domain was generated by site-directed mutagenesis to generate
pLV-pacsin2-[R50D]-GFP. A membrane localization mutant was generated by
mutating methionine at position 124 and 125 (ATG ATG) to glutamic acid (GAG
GAG). An SH3 mutant was generated by mutating proline at position 478 (CCG)
to leucine (CTG) in pacsin2. Mouse a-catenin-mCherry and human Rab4a-GFP
were cloned into the pLV-CMV-ires-puro vector using NdeI and NheI restriction
sites. The lentiviral expression constructs pLV-a-catenin-Dendra2, pLV-VE-cad-
herin-GFP and pLV-p120-catenin-mCherry have been previously described24.
Mammalian expression vectors for myc-tagged pacsin1, and pacsin3- and
mCherry-tagged Rac1 wild type and Q61L, were previously reported33. Transient
transfection of these constructs was performed with TransIT-LT1 (Mirus)
according to the manufacturers’ standard protocol. Pacsin2 expression was
knocked down using shRNA expression plasmids from The RNAi Consortium
(TRC) library60. shRNA encoding pLKO.1 lentiviral vectors targeting human
pacsin2 were MISSION TRC1 clones 0000037979, 0000037980, 0000037981,
0000037982 and 0000037983 from Sigma-Aldrich. The 0000037980 and
0000037983 constructs induced most efﬁcient knockdowns in HUVECs.
Non-targeting shRNA (SHC002; Sigma-Aldrich) was used as a negative control.
For rescue experiments a short hairpin directed against the 30-UTR of human
pacsin2, shPacsin2-TagRFP, was designed. The shRNA was created by allowing
two oligo’s containing the shRNA sequence (50-CCGGTGTCATGTCTCAGT
GTCTATCTCTCGAGAGATAGACACTGAGACATGACTTTTTG-30) to self-
ligate and subsequently insert the shRNA into a modiﬁed version of the pLKO.1
backbone between the AgeI and EcoRI restriction sites. Lentiviral particles were
isolated from the supernatant of HEK293T cells transiently transfected with third-
generation packaging constructs and the lentiviral expression vectors. HUVECs,
cultured to 80% conﬂuency, were infected with supernatant containing lentiviral
particles overnight. Cells were analysed at least 48 h after transduction. To
obtain cells expressing both shPacsin2-TagRFP and pacsin2 rescue constructs,
cells were sorted on FACSARIATM III cell sorter (BD) for TagRFP and GFP
dual positivity.
Antibodies and reagents. Mouse monoclonal anti-actin (clone AC-40, Cat #
A3853, diluted 1/3,000 for western) anti-vinculin antibody hVIN-1 (Cat # V9131,
diluted 1/100 for immunoﬂuorescence (IF)), rabbit anti-a-catenin serum (Cat #
C2081, diluted 1/400 for IF) and anti-b-catenin serum (Cat # C2206, diluted 1/400
for IF) were obtained from Sigma-Aldrich. Mouse monoclonal anti-p120-catenin
Figure 8 | Pacsin2 association precedes VE-cadherin internalization. (a) Wideﬁeld time-lapse images of FAJs in HUVECs expressing pacsin2-GFP
(green) and a-catenin-mCherry (red). Arrows follow a-catenin-mCherry internalizing from the junction to vesicles (red dots) and show pacsin2-GFP
association during junctional internalization. See corresponding Supplementary Movie 11 for a 12-min time-lapse recording. (b) Wideﬁeld IF images of
HUVECs pre-labelled with monoclonal 55/7H1 anti-VE-cadherin antibody and subsequently stained for Rab5. Arrowheads point to internalized VE-
cadherin at Rab5-positive vesicles. (c,d) Wideﬁeld IF images of HUVECs expressing Rab4-GFP (c) or Rab11 (d) and live-labelled with monoclonal 55/7H1
anti-VE-cadherin antibody. Arrowheads point to internalized VE-cadherin at Rab4-positive vesicles. (e) Wideﬁeld IF images of HUVECs expressing Rab4-
GFP and IF stained for total VE-cadherin. Arrowheads point to VE-cadherin at Rab4-positive vesicles. (f) Wideﬁeld IF images of HUVECs pre-labelled with
monoclonal 55/7H1 anti-VE-cadherin antibody and subsequently stained for VEGFR2. Arrowheads point to internalized VE-cadherin at VEGFR2-positive
vesicles. (g) Whisker dot plot shows the average±s.e.m. Mander’s split coefﬁcient (colocalization analysis) of pixel intensities of cytoplasmic VE-cadherin
against indicated vesicular proteins. nZ19 cells per correlation analysis from nZ2 independent experiments. The Mander’s split coefﬁcient value indicates
the fraction of detected VE-cadherin pixels colocalizing with the analysed vesicle proteins. (h) Graph shows the average portion of vesicles±s.e.m. that are
positive for internalized VE-cadherin (black bar) or exo-endocytosed VE-cadherin (white bar). VE-cadherin-GFP was expressed in a sparse fraction of
endothelial cells (donor cells) and VE-cadherin internalization was monitored in neighbouring adhered non-transduced cells (acceptor cells). Subsequently,
we surface-chased VE-cadherin for 2 h using Alexa-647-labelled 55/7H1 antibody and determined the number of GFPþAlexa647þ (exo-endocytosed)
versus GFP-Alexa647þ (internalized) vesicles in acceptor cells. Analysis was performed on n¼ 27 cells from three independent experiments.
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antibody (clone 98/pp120, Cat # 610133, diluted 1/100 for IF), anti-b-catenin
(clone 14, Cat # 610154, diluted 1/100 for IF), anti-N-cadherin (clone 32, Cat #
610920, diluted 1/100 for IF) and anti-Rho GDI (Cat # 610255, diluted 1/5,000 for
western) were from BD Bioscience. Rabbit polyclonal anti-pacsin2 antibody was
from Abcam (Cat # ab118330, diluted 1/100 for IF and 1/1,000 for western), and
anti-pacsin1 and anti-pacsin3 rabbit sera were a kind gift from Dr Markus Ploman.
Rabbit anti-nostrin was a generous gift of Dr Stefanie Oess. Monoclonal antibodies
against serine 19 phosphorylated myosin light chain 2 (Cat # 3675, diluted 1/50 for
IF) and Rab5 (clone C8B1, Cat # 3547, diluted 1/100 for IF) were from Cell
Signaling. To detect VE-cadherin, we used the following mouse monoclonal
anti-VE-cadherin antibodies: clone 75 (BD Bioscience, Cat # 610252, diluted 1/100
for IF and 1/1,000 for western), clone F-8 (Santa Cruz, Cat # SC-9989,
diluted 1/100 for IF) and clone 55-7H1 directly coupled to Alexa-Fluor 647
(BD Pharmingen, Cat # 561567, diluted 1/500 for cell surface labellings); rabbit
polyclonal antibody (Cayman, Cat # 160840, diluted 1/500 for IF and 1/2,500
for western) and goat polyclonal antibody (C-19 Santa Cruz, Cat # SC-6458,
diluted 1/200 for IF and 1/3,000 for western). We used Acti-stain 555
(Cytoskeleton, Inc. Cat # PHDH1, diluted 1/500 for IF) or Promoﬂuor 415-coupled
phalloidin (Promokine, Cat # PK-PF415-7-01, diluted 1/250 for IF) to visualize
F-actin. Secondary antibodies coupled to Alexa-Fluor 488, 568, 594 and 647 were
obtained from Molecular Probes (Life Technologies) and all diluted 1/500. Bovine
plasma-derived ﬁbronectin was purchased from Sigma-Aldrich.
IF microscopy. For standard IF staining, cells were cultured on coverslips coated
with 5 mgml 1 ﬁbronectin and subsequently ﬁxed in 4% paraformaldehyde in PBS
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(supplemented with 1mM CaCl2 and 0.5mM MgCl2; PBSþ þ ) for 10min,
permeabilized with 0.5% Triton X100 in PBS for 5min and blocked for 30min with
2% bovine serum albumin (BSA) in PBS. For the scratch assays HUVECs were
cultured overnight. A scratch was made across the cell layer using a sterile pipette
tip, and cells were allowed to recover and migrate for 4 h before ﬁxation and IF
staining. Primary and secondary antibody stainings were performed in 0.5% BSA in
PBS for 1 h, and coverslips were mounted in Mowiol4-88/DABCO solution. For the
IF stainings in Figs 7b,c and 8b,c,d,f, surface VE-cadherin was pre-labelled with an
Alexa-Fluor-647-conjugated non-blocking anti-extracellular VE-cadherin antibody
(mouse monoclonal 55/7H1) in EGM-2 medium at 37 C for 30min. After 1–2 h
culturing these cells were ﬁxed in paraformaldehyde and stained for surface
VE-cadherin with mouse monoclonal 75 antibody (Fig. 7b,c) or indicated
endogenous proteins. For the IF stainings in Fig. 9d, HUVECs were pre-labelled
with 55/7H1 antibody in EGM-2 medium at 4 C for 30min and internalization
was followed after 2 h of culturing the cells at 37 C. To visualize intracellular
proteins, VE-cadherin-labelled cells were permeabilized in 0.5% Triton X100 in
PBS for 5min and stained according to the standard IF protocol. Mesenteric
arteries were stored in PBSþ þ at 4 C for no longer than 24 h after surgery until
further preparation as described previously25. IF stained samples were imaged
using inverted Zeiss wideﬁeld microscopes Observer.Z1 equipped with a 63 1.40
Plan Apochromat oil objective, and Axiovert 200 equipped with a 63 1.25
numerical aperture (NA) EC Plan Neoﬂuar oil objective, and AxioCAMMR3 and
Hamamatsu Orca-R2 digital cameras. Confocal imaging of VE-cadherin and
pacsin2 in HUVEC (Supplementary Movie 1), and human mesenteric arteries
(Fig. 1f) were made by confocal laser scanning microscopy (Zeiss LSM 510) using a
63 /1.4 NA oil objective and argon 488 and DPSS 561 nm lasers. For the imaging
of VE-cadherin, pacsin2, Rac1 and F-actin in Fig. 3c, a LEICA TCS SP8 confocal
microscope system equipped with a 63 1.4 NA oil objective, and 405 nm diode,
488 nm argon, 594 nm HeNe and 633 nm HeNe lasers, was used. Images were
enhanced for display with an unsharp mask ﬁlter and adjusted for brightness/
contrast in ImageJ (National Insitutes of Health).
Live cell ﬂuorescence microscopy. For live microscopy, cells were plated on
Lab-Tek-chambered 1.0 borosilicated coverglass slides coated with 5 mgml 1
ﬁbronectin and imaged within microscope incubators at 37 C and 5% CO2.
Wideﬁeld imaging (Figs 3d,4b and 8a; Supplementary Movies 2–8,11 and 12) was
performed on an inverted Zeiss wideﬁeld Observer.Z1 microscope equipped with a
63 1.40 Plan Apochromat oil objective, deﬁnite focus system, and Hamamatsu
Orca-R2 digital camera. For the Dendra2 photoswitching experiments (Fig. 6a;
Supplementary Movie 9), a LEICA TCS SP8 confocal microscope system equipped
with a 63 1.4 NA oil objective, and 405 nm diode, 488 nm argon and 594 nm
HeNe lasers were used. Regions of interest were photoswitched by a focused
405 nm diode laser beam illumination using the LEICA FRAP module. FRAP
experiments (Figs 6b and 9f; Supplementary Movie 10) were performed on a Zeiss
LSM 510 Meta confocal laser scanning microscope using a 40 1.3 NA EC Plan
Neoﬂuar oil objective, and argon 488 and DPSS 561 nm lasers. A deﬁned area of
interest (9.64 mm2) was photobleached by 200 iterations using the DPSS laser at
561 nm at maximal power (15mW). Images were enhanced for display with an
unsharp mask ﬁlter and adjusted for brightness/contrast in ImageJ.
Super-resolution microscopy. STED microscopy was performed on a Leica TCS
SP8 STED 3X microscope. HUVEC monolayers were stained using the following
antibodies: rabbit polyclonal anti-pacsin2 (Abcam), mouse monoclonal anti-vin-
culin hVIN-1 (Sigma), mouse monoclonal anti-p120-catenin clone 98/pp120 (BD
Bioscience), rabbit anti-a-catenin and anti-b-catenin serum (Sigma) combined
with anti-VE-cadherin mouse monoclonal F-8 (Santa Cruz) or rabbit polyclonal
(Cayman) antibodies. Secondary antibodies used were STAR 580 and STAR 635P
(Abberior). Samples were irradiated with a pulsed white light laser at wavelengths
587 and 633 nm. A pulsed STED laser line at a wavelength of 775 nm was used for
the depletion of the 587- and 633-nm ﬂuorophore, reaching a lateral resolution of
B45 nm to distinguish individual ﬂuorescent signals in these IF stainings. The
signal was detected using a gated hybrid detector in counting mode. STED images
were acquired using a dedicated 100 1.4 NA oil objective. Finally, deconvolution
was performed with Huygens Professional (Scientiﬁc Volume Imaging).
Western blot analysis. Cell lysates were prepared in reduced sample buffer and
analysed by standard western blotting and enhanced chemiluminescence detection.
Uncropped scans of blots are presented in Supplementary Fig. 3.
Flow cytometry. For ﬂow cytometry analysis in Fig. 9b, cells were collected with
Accutase cell detachment solution (GE healthcare), blocked in PBS containing 1%
BSA, incubated with anti-surface VE-cadherin antibody using Alexa-Fluor-647-
conjugated mouse monoclonal 55/7H1 for 45min at 4 C, and subsequently
analysed on a FACS CANTO II (Becton Dickinson).
Electric cell–substrate impedance sensing. Endothelial barrier function was
determined by measuring the electrical resistance of monolayers by ECIS. Electrode
arrays (8W10E; IBIDI) were treated with 10mM L-cysteine (Sigma) for 15min at
37 C and subsequently coated with 10 mgml 1 ﬁbronectin (Sigma) in 0.9% NaCl
for 1 h at 37 C. Cells were seeded and electrical resistance was continuously
measured during monolayer formation at 30 kHz using ECIS model 9600 (Applied
BioPhysics) and 37 C at 5% CO2 incubator conditions. Resistane values were
corrected for background signal that was measured in ECIS wells without cells
(274Ohm, n¼ 2). In Fig. 9i, values are normalized to the resistance of shControl
cells. The barrier capacity during junction formation was determined at 4 h after
cell seeding, and for established monolayers at 16 h after cell seeding.
Image and statistical analysis. For evaluations of ﬂuorescence signals along
linescans in IF images (Fig. 1a,d,g and 4a,b), ﬂuorescence integrated intensities was
measured along junctional linescans, corrected for the integrated intensity along
linescans in the cytoplasm in direct proximity of the junction. A measure of 8 mm
linescans were made along random junctions in the original imaging data using
ImageJ. The categorization of FAJs and linear adherens junctions was based on
phenotypic organization of VE-cadherin signal. FAJs are deﬁned as interrupted and
perpendicularly oriented junctions between cells. For symmetric ratio analysis at
FAJs (Figs 1d and 6a), the background-corrected integrated ﬂuorescence intensities
along linescans were split into two halves of which the values of the trailing
end side of junctions were divided by the values of their opposite side. A ratio of 1
represents symmetric distribution along FAJs. The evaluation of the
percentage±s.e.m. of FAJs that are pacsin2- or nostrin-positive was calculated
manually in wideﬁeld images (Figs 1c,g and 2). The orientation angle of pacsin2 at
FAJs, in relation to the front of the scratch wound or the bottom of the image in
control monolayers (Fig. 3a), was obtained by linescans from the front to the
pacsin2-positive trailing end along every pacsin2-positive FAJ within a distance of
four cell rows from the scratch front. To determine the average near junctional
intensities of activated myosin light chain (Fig. 3b), the local integrated
ﬂuorescence instensity of p-MLC Ser19 signal was measured in ﬁxed square areas
of 18mm2 at the pacsin2-positive versus pacsin2-negative side of FAJs. The values
are corrected for background and normalized to maximal intensities in the overall
image. To determine the speed of FAJ movement (Fig. 4b), FAJ trailing ends were
tracked using the MtrackJ plugin of ImageJ in time-lapse recordings of 150 s.
Pearson’s split colocalization coefﬁcients (Fig. 5b) were calculated using ImageJ.
To examine colocalization of VE-cadherin with vesicles (Fig. 8g), the Mander’s split
Figure 9 | Pacsin2 controls VE-cadherin internalization and endothelial barrier. (a) Western blot analysis of VE-cadherin, pacsin2 and Rho GDI (loading
control) in lysates of HUVECs transduced with shControl or shPacsin2#4. (b) Flow cytometry analysis of VE-cadherin surface expression on HUVECs
transduced with shControl or shPacsin2#4. (c) Wideﬁeld IF images of HUVECs transduced with shControl or shPacsin2#4 stained for pacsin2 (green) and
VE-cadherin (red); or ZO-1 (green), VE-cadherin (red) and F-actin (blue). See also Supplementary Fig. 2b. (d) Wideﬁeld IF images of HUVECs transduced
with shControl or shPacsin2#4 and surface-chased VE-cadherin using monoclonal 55/7H1 and stained for F-actin (blue). Graph shows the average
number±s.e.m. of VE-cadherin-positive internalized vesicles per cell. nZ100 cells from four independent experiments. (e) Western blot analysis of VE-
cadherin, pacsin2 and actin (loading control) in lysates of HUVECs transduced with shControl or shPacsin2#4. Long exposure of VE-cadherin stainings
show a 100 kDa fragment, which is associated with internalized VE-cadherin46. Graph shows the average intensity±s.e.m. of the 100 kDa VE-cadherin
fragment normalized for actin loading from four independent experiments. (f) Line graph shows the average recovery of a-catenin-mCherry ﬂuorescence
signal as a percentage of the signal before bleaching at the trailing end of FAJs of HUVECs transduced with shControl (n¼ 13 independent experiments) or
shPacsin2#4 (n¼ 8 independent experiments). Bar graph shows the average±s.e.m. recovered mobile fraction of a-catenin-mCherry ﬂuorescence signal
in between 100 and 125 s after bleaching. (g) Graph shows the average transendothelial resistance±s.e.m. of shControl, shPacsin2#4 and shPacsin2#2
transduced HUVECs during junction formation or established junctions. n¼ 3 independent experiments. (h) Western blot analysis of pacsin2 and actin
(loading control) in lysates of FACS-sorted HUVECs expressing shControl or shPacsin2 30-UTR and rescued with GFP-tagged pacsin2, pacsin2[R50D] or
pacsin2 [P478L]. Asterisk marks a degradation band of pacsin2[R50D] that runs around the same height as endogenous pacsin2. (i) Graph shows the
average transendothelial resistance±s.e.m. of shControl, shPacsin2 30-UTR or indicated rescued HUVECs during junction formation or established
junctions. n¼ 6 independent experiments. *Pr0.05; **Pr0.01 (Student’s t-test).
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coefﬁcient of pixel intensities of VE-cadherin against vesicular proteins was
determined speciﬁcally in the cytoplasm of cells and junctional regions were
excluded from the analysis in background-subtracted images using automated
Costes thresholding in ImageJ61. Quantiﬁcation of the number of vesicles (Figs 8h
and 9d) was performed by manually counting vesicles in the cytoplasm using the
Find Maxima tool of ImageJ applying a predetermined noise tolerance value.
Averages and s.e.’s of the mean were calculated and are shown in the graphs with
corresponding n values and number of independent experiments. P values are the
result of two-tailed, homoscedastic Student’s t-tests.
Data availability. The data that support the ﬁndings of this study are available
from the corresponding author upon request.
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